Poly Medicure Fair Value
Poly Medicure (POLYMED) average fair value is ₹572.62 across 8 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹1512.1 (-62.13%), fair value range ₹155.26–₹1751.8. For live price and a broader fundamental view, visit POLYMED stock overview.
Fair Value Analysis Export
POLYMED Fair Value vs Current Price — Valuation Summary
POLYMED average fair value, fair value range, price gap and valuation status across 8 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). Review POLYMED price earnings ratio to evaluate earnings-based valuation against sector peers.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Benjamin Graham Number
Discounted Cash Flow (DCF)
POLYMED Fair Value Analysis — Data Sources & Coverage
Poly Medicure financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Also explore POLYMED price movement history to track price trends across different timeframes.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
POLYMED vs Healthcare Sector Peers — P/E, P/B & Market Cap
Poly Medicure P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 16.94 | 2.55 | ₹115 |
| Jeena Sikho Lifecare | JSLL | 41.45 | 23.68 | ₹8,396 |
| Par Drugs & Chemical | PAR | 8.09 | 1.06 | ₹113 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sat Kartar Life | SATKARTAR | 32.1 | 6.11 | ₹320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.